Ethical Considerations

Authors are advised to read carefully the publication guidelines available at ‘Committee On Publication Ethics’ (COPE) website ‘https://publicationethics.org/’. If tables, illustrations or photographs, which have already been published, are included, a letter of permission for re-publication should be obtained from author(s) as well as the editor/publisher of the journal where it was previously published. Written permission to reproduce photographs of patients, whose identity is not disguised, should be sent with the manuscript; otherwise the eyes will be blackened out. If a medicine is used, generic name should be used. The commercial name may, however, be mentioned within brackets, only if necessary. In case of medicine or device or any material indicated in text, a declaration by author/s should be submitted that no monetary benefit has been taken from manufacturer/importer of that product by any author. In case of experimental interventions, permission from ethical committee of the hospital should be taken beforehand. Any Conflict of Interest must be disclosed. All interventional studies submitted for publication should carry Institutional Ethical & Research Committee approval letter. Ethical consideration regarding the intervention, added cost of test, and particularly the management of control in case control comparisons of trials should be addressed: multicentric authors’ affiliation may be asked to be authenticated by provision of permission letters from ethical boards or the heads of involved institutes.